MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.

导出 OA

翻译打印收藏纠错

作者： Briete,Goorts ^[1] ; Kelly M A,Dreuning ^[2] ; Janneke B,Houwers ^[3] ; Loes F S,Kooreman ^[4] ; Evert-Jan G,Boerma ^[5] ; Ritse M,Mann ^[6] ; Marc B I,Lobbes ^[7] ; Marjolein L,Smidt ^[8]

作者单位： GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. b.goorts@hotmail.com. ^[1] Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands. b.goorts@hotmail.com. ^[2] Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. b.goorts@hotmail.com. ^[3] Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands. ^[4] Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. ^[5] GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. ^[6] Department of Pathology, Maastricht University Medical Center, Maastricht, the Netherlands. ^[7] Department of Surgery, Zuyderland Medical Center, Sittard-Geleen, the Netherlands. ^[8] Department or Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. ^[9]

关键词 Breast Cancer Magnetic resonance imaging Neoadjuvant chemotherapy